Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence

Clinical trial NCT01903005 · COMPLETED

Trial details

NCT number: NCT01903005
Sponsor: Orexo AB
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Opioid Dependence, on Agonist Therapy

Start date: 2013-07-01
Primary completion: 2014-09-01
Enrollment: 668

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.